Arthur Johnson, MD
Neurological Surgery · Fort Smith, ARNPI 1154399590
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,967 of the $2,222 with a category attached, or 88.5%. 14 manufacturers reported payments, led by Nanovis LLC at 33.0% of the total. Reporting peaked in 2019 at $629 and has fallen 87.1% since, to $81 in 2025. That places this record below the midpoint for neurological surgery clinicians in AR, where the typical reported total is $2,360.
Across 55 payments — averaging $40.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nanovis LLC$733
- Si-bone, Inc.$613
- Medtronic$376
- Johnson & Johnson$82
- Arteriocyte Medical Systems, Inc.$80
- Abbott$70
- plus $267 from 8 others
What the payments were for
- Travel & lodging$25411%
- Food & beverage$1,96789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nanovis LLC | 3 | $733 |
| Si-bone, Inc. | 12 | $613 |
| Medtronic(2 entities) | 21 | $376 |
| Johnson & Johnson | 4 | $82 |
| Arteriocyte Medical Systems, Inc. | 1 | $80 |
| Abbott | 4 | $70 |
| Haemonetics Corporation | 1 | $67 |
| DJO, LLC | 2 | $62 |
| Aesculap, Inc. | 2 | $39 |
| Argenx US, Inc. | 1 | $25 |
| MDD US Operations, LLC | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $14 |
How this compares
$2,222 in reported general payments places this provider in the 45th percentile of 64 neurological surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 11 | $994 |
| Cephalexin | 12 | $142 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $128 |
| Tizanidine Hcl | 18 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Fort Smith
- Timothy MaryanovFort Smith$5K
- Joseph QueeneyFort Smith$765
- Erika PetersenLittle Rock$663K
- James BlankenshipFayetteville$217K
- Keith NorvillHot Springs$91K
- Muhammad KandelHot Springs$76K
- John DayLittle Rock$44K
- Dominic MaggioLittle Rock$34K
- Fred JordanNorth Little Rock$32K
- James CalhounNorth Little Rock$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.